Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines

Journal of Cellular Physiology

Volumn 222, Issue 3, 2010, Pages 596-605

  Lapyckyj, Lara ^a   Castillo, Lilian Fedra ^a   Matos, María Laura ^a   Gabrielli, Nieves María ^a   Lüthy, Isabel Alicia ^a   Vazquez Levin, Mónica Hebe ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA CATENIN; DYSADHERIN; MESSENGER RNA; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC CODE; GENOMICS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STRESS FIBER; UPREGULATION;

ACTINS; BETA CATENIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS FIBERS; TWIST TRANSCRIPTION FACTOR;

EID: 73649102045     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21974     Document Type: Article

References (67)

1. Angst BD, Marcozzi C, Magee AI. 2001. The cadherin superfamily. J Cell Sci 114:625-626.
2. Batistatou A, Peschos D, Tsanou H, Charalabopoulos A, Nakanishi Y, Hirohashi S, Agnantis NJ, Charalabopoulos K. 2007. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. Br J Cancer 96:1404-1408.
3. Bertucci F, Orsetti B, Negre V, Finetti P, Rouge C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, WangQ, Benard J, Puisieux A, Birnbaum D, Theillet C. 2008. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 27:5359-5372.
4. Berx G, van Roy F. 2001. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3:289-293.
5. Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJ, van d V, Cornelisse C, van Roy F. 1995a. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115.
6. Berx G, Staes K, Van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. 1995b. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26:281-289.
7. Berx G, Cleton-Jansen AM, Strumane K, De Leeuw WJ, Nollet F, van Roy F, Cornelisse C. 1996. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
8. Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R. 2002. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev 115:53-62.
9. Bruzzone A, Vanzulli SI, Soldati R, Giulianelli S, Lanari C, Luthy IA. 2009. Novel Human Breast Cancer Cell Lines IBH-4, IBH-6 and IBH-7 Growing in Nude Mice. J Cell Physiol 219:477-484.
10. Bryant DM, Stow JL. 2004. The ins and outs of E-cadherin trafficking. Trends Cell Biol 14:427-434.
11. Cheng GZ, Chan J,WangQ, Zhang W, Sun CD, Wang LH. 2007. Twist transcriptionally upregulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67:1979-1987.
12. Cleton-Jansen AM. 2002. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: Different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 4:5-8.
13. Conacci-Sorrell M, Zhurinsky J, Ben Ze'ev A. 2002. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991.
14. Corsino PE, Davis BJ, Norgaard PH, Parker NN, Law M, Dunn W, Law BK. 2008. Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component. Neoplasia 10:1240-1252.
15. Cowin P, Rowlands TM, Hatsell SJ. 2005. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17:499-508.
16. Delmas V, Larue L. 2004. Cadherins in the mammary gland and the melanocyte lineage. J Soc Biol 198:385-389.
17. Gupta A, Deshpande CG, Badve S. 2003. Role of E-cadherins in development of lymphatic tumor emboli. Cancer 97:2341-2347.
18. Hartsock A, Nelson WJ. 2008. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 1778:660-669.
19. Havaki S, Kouloukoussa M, Amawi K, Drosos Y, Arvanitis LD, Goutas N, Vlachodimitropoulos D, Vassilaros SD, Katsantoni EZ, Voloudakis-Baltatzis I, Aleporou-Marinou V, Kittas C, Marinos E. 2007. Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell Int 7:16.
20. Hazan RB, Kang L, Whooley BP, Borgen PI. 1997. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4:399-411.
21. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. 2000. Exogenous expression of Ncadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790.
22. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, Doggett N, Johnson K, Wheelock M, Herman J, Baylin S, Pinkel D, Gray J. 1998. Mechanisms of inactivation of Ecadherin in breast cancer cell lines. Cancer Res 58:1972-1977.
23. HugueninM, Muller EJ, Trachsel-Rosmann S, Oneda B, AmbortD, Sterchi EE, Lottaz D. 2008. The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion. PLoS ONE 3:e2153.
24. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S. 1999. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 81:1103-1110.
25. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. 2002. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99:365-370.
26. Janda E, Nevolo M, Lehmann K, Downward J, Beug H, Grieco M. 2006. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene 25:7117-7130.
27. Jeanes A, Gottardi CJ, Yap AS. 2008. Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene 27:6920-6929.
28. Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K. 2007. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Anticancer Res 27:1969-1974.
29. Johnson SK, Ramani VC, Hennings L, Haun RS. 2007. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109:1811-1820.
30. King JA, Shevde LA, Ofori-Acquah S,Watkins G, Jiang WG. 2008. Is N-cadherin expression important in ductal carcinoma? South Med J 101:470-475.
31. Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, Flechtenmacher C, Angel P, Hess J. 2007. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res 67:8198-8206.
32. Leckband D. 2008. Beyond structure: Mechanism and dynamics of intercellular adhesion. Biochem Soc Trans 36:213-220.
33. Lo HW, Hsu SC, XiaW, Cao X, Shih JY, Wei Y, Abbruzzese JL, Hortobagyi GN, Hung MC. 2007. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066-9076.
34. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK. 2002. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21:1948-1956.
35. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P. 2005. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102:9182-9187.
36. Mosesson Y,Mills GB, Yarden Y. 2008. Derailed endocytosis: An emerging feature of cancer. Nat Rev Cancer 8:835-850.
37. Nagae Y, Kameyama K, Yokoyama M, Naito Z, Yamada N, Maeda S, Asano G, Sugisaki Y, Tanaka S. 2002. Expression of E-cadherin catenin and C-erbB-2 gene products in invasive ductal-type breast carcinomas. J Nippon Med Sch 69:165-171.
38. NamJS, Kang MJ, Suchar AM, ShimamuraT, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM. 2006. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66:7176-7184.
39. Nam JS, Hirohashi S,Wakefield LM. 2007. Dysadherin: A new player in cancer progression. Cancer Lett 255:161-169.
40. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. 1999. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147:631-644.
41. Niessen CM, Gumbiner BM. 2002. Cadherin-mediated cell sorting not determined by binding or adhesion specificity. J Cell Biol 156:389-399.
42. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, SteelantW, Bruyneel E, Matrisian LM, Mareel M. 2001. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114:111-118.
43. Nose A, Tsuji K, TakeichiM. 1990. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61:147-155.
44. Palacios F, Tushir JS, Fujita Y,D'Souza-Schorey C. 2005. Lysosomal targeting of E-cadherin: A unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 25:389-402.
45. Parkin DM, Fernandez LM. 2006. Use of statistics to assess the global burden of breast cancer. Breast J 12:S70-S80.
46. Pawlak G, Helfman DM. 2001. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11:41-47.
47. Peinado H, Portillo F, Cano A. 2004. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48:365-375.
48. Polkowski WP, Skomra DG, Mielko J,Wallner GT, Szumilo J, Zinkiewicz K, Korobowicz EM, van Lanschot JJ. 2004. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia. Eur J Surg Oncol 30:1084-1092.
49. Prasad CP, Gupta SD, Rath G, Ralhan R. 2007. Wnt signaling pathway in invasive ductal carcinoma of the breast: Relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology 73:112-117.
50. Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, Day ML. 2003. The role of calpain in the proteolytic cleavage of E-cadherin in prostate andmammary epithelial cells. J Biol Chem 278:1372-1379.
51. Ryniers F, Stove C, Goethals M, Brackenier L, Noe V, Bracke M, Vandekerckhove J, Mareel M, Bruyneel E. 2002. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 383:159-165.
52. Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S. 2003. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: Relationship to e-cadherin expression. J Clin Oncol 21:659-667.
53. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. 1996. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.AmJ Clin Pathol 105:394-402.
54. Sormunen RT, Leong AS, Vaaraniemi JP, Fernando SS, Eskelinen SM. 1999. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model. J Pathol 187:416-423.
55. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. 2001. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 276:4972-4980.
56. Takeichi M. 1993. Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811.
57. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
58. Turashvili G, Bouchal J, Ehrmann J, Fridman E, Skarda J, Kolar Z. 2007. Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 151:59-64.
59. van Roy F, Berx G. 2008. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65:3756-3788.
60. Vazquez SM, Mladovan A, Garbovesky C, Baldi A, Luthy IA. 2004. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: Functional characterization. J Cell Physiol 199:460-469.
61. Vesuna F, van Diest P, Chen JH, Raman V. 2008. Twist is a transcriptional repressor of Ecadherin gene expression in breast cancer. Biochem Biophys Res Commun 367:235-241.
62. WatanabeO, ImamuraH, Shimizu T, Kinoshita J, Okabe T, HiranoA, Yoshimatsu K, Konno S, Aiba M, Ogawa K. 2004. Expression of twist and wnt in human breast cancer. Anticancer Res 24:3851-3856.
63. WeisWI, NelsonWJ. 2006. Re-solving the cadherin-catenin-actin conundrum. J Biol Chem 281:35593-35597.
64. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. 2008. Cadherin switching. J Cell Sci 121:727-735.
65. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A,Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939.
66. Yang JY, Zong CS, Xia W, Wei Y, Ali-Seyed M, Li Z, Broglio K, Berry DA, Hung MC. 2006. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol 26:7269-7282.
67. Yap AS, Kovacs EM. 2003. Direct cadherin-activated cell signaling: A view from the plasma membrane. J Cell Biol 160:11-16.